June 30 - July 7, 2016
Last Updated: Jul 01, 2016
- Drawing the Line in Risk-Reducing Gynecologic Surgery in Women With a BRCA Mutation
CA Leath et al, JAMA Oncology, July 1, 2016 - Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations
CA Shu et al, JAMA Oncology, July 1, 2016 - Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Chiba Akiko et al. Annals of surgical oncology 2016 Jun - The integration of BRCA testing into oncology clinics.
Percival Natalie et al. British journal of nursing (Mark Allen Publishing) 2016 Jun 25(12) 690-4 - A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.
Roviello Giandomenico, et al. Future oncology (London, England) 2016 6 - Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?
van Tilborg Theodora C, et al. Menopause (New York, N.Y.) 2016 6 - Germline Mutations in DNA Repair Genes May Predict Neoadjuvant Therapy Response in Triple Negative Breast Patients.
Spugnesi Laura, et al. Genes, chromosomes & cancer 2016 6 - Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
Streff Haley et al. The oncologist 2016 Jun - BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Ewald Ingrid Petroni, et al. Genetics and molecular biology 0 0 (2) 223-31 - Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
Ossa Carlos Andrés et al. The oncologist 2016 Jun - Physician Risk Assessment Knowledge Regarding BRCA Genetics Testing.
Cohn Jason et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2015 Sep 30(3) 573-9 - Bias explains most of the parent-of-origin effect on breast cancer risk in BRCA1/2 mutation carriers.
Vos Janet R, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 6 - Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.
Kolben Thomas, et al. Anticancer research 2016 6 (6) 3185-90 - Genetic testing for hereditary breast cancer in Asia-moving forward.
Kwong Ava, et al. Chinese clinical oncology 2016 6 (3) 47 - Exclusive: Breast cancer gene database gives clearer picture of risk,
by Susan Miller, USA Today, June 1, 2016
- Human (38)
- Pathogen (0)
- Human (464)
- Pathogen (0)
- Human (130)
- Pathogen (0)
.jpg)
No hay comentarios:
Publicar un comentario